Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes

ABSTRACT Most anticancer drugs like doxorubicin (DXR) have low specificity that results in undesirable effects especially when it comes to collateral effects on reproduction. Plants are excellent sources when searching for new drugs. Auxemma oncocalyx (A. oncocalyx) and its main component Oncocalyxone A (onco A) have anti-tumoral activity and are less toxic than DXR in reproductive parameters. However, there are no studies on the action of these drugs regarding the porcine in vitro oocyte competence and embryo development. The aim of this study was to evaluate the effect of A. oncocalyx and onco A exposure during in vitro maturation (IVM) of oocytes (Experiment 1) or in vitro embryo culture (IVC) (Experiment 2) on the oocyte developmental competence. For experiment 1, COCs were distributed in IVM medium alone (control) or supplemented with DXR (0.3 (g/mL), A. oncocalyx (1.2 (g/mL) and onco A (1 (g/mL). Then, oocytes were submitted to in vitro fertilization (IVF) and in vitro embryo culture. For experiment 2, zygotes were cultured with DXR, A. oncocalyx and onco A for 7 days. Viability, maturation, fertilization and embryo developmental parameters were evaluated in both experiments. In experiment 1; DXR, A. oncocalyx and onco A reduced (P<0.05) oocyte viability and IVM efficiency. Onco A increased (P<0.05) the meiotic resumption. After IVF, all drugs reduced (P<0.05) viability, IVF efficiency and percentage of cleaved embryos, nevertheless, only DXR decreased the percentage of blastocyst. In experiment 2; all drugs reduced (P<0.05) the percentage of penetration, but only DXR and onco A decreased (P<0.05) IVF efficiency. DXR and A. oncocalyx decreased (P<0.05) the percentage of cleaved embryo, but had no effect on blastocyst formation. In conclusion, the addition of DXR during IVM or IVC negatively affected the IVF efficiency and cleavage rate. In addition, the exposure of COCs to DXR only during IVM was more detrimental to oocyte viability and blastocyst formation than A. oncocalyx and onco A.

Saved in:
Bibliographic Details
Main Authors: Revilla,Johanna Leiva, Maside,Carolina, Vieira,Luis, Cadenas,Jesús, Acioly,Ana Clara Ferreira, Paes,Victor Macedo, Agiar,Francisco Leo, Celestino,Juliana Jales de Hollanda, Alves,Benner Geraldo, Pessoa,Otilia Deusdenia Loiola, Toniolli,Ricardo, Rodrigues,Ana Paula, Figueiredo,José Ricardo de
Format: Digital revista
Language:English
Published: Sociedad Científica del Paraguay 2019
Online Access:http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2617-47312019000200274
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2617-47312019000200274
record_format ojs
spelling oai:scielo:S2617-473120190002002742020-08-11Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytesRevilla,Johanna LeivaMaside,CarolinaVieira,LuisCadenas,JesúsAcioly,Ana Clara FerreiraPaes,Victor MacedoAgiar,Francisco LeoCelestino,Juliana Jales de HollandaAlves,Benner GeraldoPessoa,Otilia Deusdenia LoiolaToniolli,RicardoRodrigues,Ana PaulaFigueiredo,José Ricardo de Auxemma oncocalyx Oncocalyxone A Doxorubicin in vitro maturation in vitro fertilization COCs embryo development ABSTRACT Most anticancer drugs like doxorubicin (DXR) have low specificity that results in undesirable effects especially when it comes to collateral effects on reproduction. Plants are excellent sources when searching for new drugs. Auxemma oncocalyx (A. oncocalyx) and its main component Oncocalyxone A (onco A) have anti-tumoral activity and are less toxic than DXR in reproductive parameters. However, there are no studies on the action of these drugs regarding the porcine in vitro oocyte competence and embryo development. The aim of this study was to evaluate the effect of A. oncocalyx and onco A exposure during in vitro maturation (IVM) of oocytes (Experiment 1) or in vitro embryo culture (IVC) (Experiment 2) on the oocyte developmental competence. For experiment 1, COCs were distributed in IVM medium alone (control) or supplemented with DXR (0.3 (g/mL), A. oncocalyx (1.2 (g/mL) and onco A (1 (g/mL). Then, oocytes were submitted to in vitro fertilization (IVF) and in vitro embryo culture. For experiment 2, zygotes were cultured with DXR, A. oncocalyx and onco A for 7 days. Viability, maturation, fertilization and embryo developmental parameters were evaluated in both experiments. In experiment 1; DXR, A. oncocalyx and onco A reduced (P<0.05) oocyte viability and IVM efficiency. Onco A increased (P<0.05) the meiotic resumption. After IVF, all drugs reduced (P<0.05) viability, IVF efficiency and percentage of cleaved embryos, nevertheless, only DXR decreased the percentage of blastocyst. In experiment 2; all drugs reduced (P<0.05) the percentage of penetration, but only DXR and onco A decreased (P<0.05) IVF efficiency. DXR and A. oncocalyx decreased (P<0.05) the percentage of cleaved embryo, but had no effect on blastocyst formation. In conclusion, the addition of DXR during IVM or IVC negatively affected the IVF efficiency and cleavage rate. In addition, the exposure of COCs to DXR only during IVM was more detrimental to oocyte viability and blastocyst formation than A. oncocalyx and onco A.info:eu-repo/semantics/openAccessSociedad Científica del ParaguayRevista de la Sociedad Científica del Paraguay v.24 n.2 20192019-12-01info:eu-repo/semantics/articletext/htmlhttp://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2617-47312019000200274en10.32480/rscp.2019-24-2.274-292
institution SCIELO
collection OJS
country Paraguay
countrycode PY
component Revista
access En linea
databasecode rev-scielo-py
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Revilla,Johanna Leiva
Maside,Carolina
Vieira,Luis
Cadenas,Jesús
Acioly,Ana Clara Ferreira
Paes,Victor Macedo
Agiar,Francisco Leo
Celestino,Juliana Jales de Hollanda
Alves,Benner Geraldo
Pessoa,Otilia Deusdenia Loiola
Toniolli,Ricardo
Rodrigues,Ana Paula
Figueiredo,José Ricardo de
spellingShingle Revilla,Johanna Leiva
Maside,Carolina
Vieira,Luis
Cadenas,Jesús
Acioly,Ana Clara Ferreira
Paes,Victor Macedo
Agiar,Francisco Leo
Celestino,Juliana Jales de Hollanda
Alves,Benner Geraldo
Pessoa,Otilia Deusdenia Loiola
Toniolli,Ricardo
Rodrigues,Ana Paula
Figueiredo,José Ricardo de
Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
author_facet Revilla,Johanna Leiva
Maside,Carolina
Vieira,Luis
Cadenas,Jesús
Acioly,Ana Clara Ferreira
Paes,Victor Macedo
Agiar,Francisco Leo
Celestino,Juliana Jales de Hollanda
Alves,Benner Geraldo
Pessoa,Otilia Deusdenia Loiola
Toniolli,Ricardo
Rodrigues,Ana Paula
Figueiredo,José Ricardo de
author_sort Revilla,Johanna Leiva
title Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
title_short Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
title_full Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
title_fullStr Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
title_full_unstemmed Analysis of the activity of oncocalyxone A (Auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
title_sort analysis of the activity of oncocalyxone a (auxemma oncocalyx) and doxorubicin on the in vitro development of porcine oocytes
description ABSTRACT Most anticancer drugs like doxorubicin (DXR) have low specificity that results in undesirable effects especially when it comes to collateral effects on reproduction. Plants are excellent sources when searching for new drugs. Auxemma oncocalyx (A. oncocalyx) and its main component Oncocalyxone A (onco A) have anti-tumoral activity and are less toxic than DXR in reproductive parameters. However, there are no studies on the action of these drugs regarding the porcine in vitro oocyte competence and embryo development. The aim of this study was to evaluate the effect of A. oncocalyx and onco A exposure during in vitro maturation (IVM) of oocytes (Experiment 1) or in vitro embryo culture (IVC) (Experiment 2) on the oocyte developmental competence. For experiment 1, COCs were distributed in IVM medium alone (control) or supplemented with DXR (0.3 (g/mL), A. oncocalyx (1.2 (g/mL) and onco A (1 (g/mL). Then, oocytes were submitted to in vitro fertilization (IVF) and in vitro embryo culture. For experiment 2, zygotes were cultured with DXR, A. oncocalyx and onco A for 7 days. Viability, maturation, fertilization and embryo developmental parameters were evaluated in both experiments. In experiment 1; DXR, A. oncocalyx and onco A reduced (P<0.05) oocyte viability and IVM efficiency. Onco A increased (P<0.05) the meiotic resumption. After IVF, all drugs reduced (P<0.05) viability, IVF efficiency and percentage of cleaved embryos, nevertheless, only DXR decreased the percentage of blastocyst. In experiment 2; all drugs reduced (P<0.05) the percentage of penetration, but only DXR and onco A decreased (P<0.05) IVF efficiency. DXR and A. oncocalyx decreased (P<0.05) the percentage of cleaved embryo, but had no effect on blastocyst formation. In conclusion, the addition of DXR during IVM or IVC negatively affected the IVF efficiency and cleavage rate. In addition, the exposure of COCs to DXR only during IVM was more detrimental to oocyte viability and blastocyst formation than A. oncocalyx and onco A.
publisher Sociedad Científica del Paraguay
publishDate 2019
url http://scielo.iics.una.py/scielo.php?script=sci_arttext&pid=S2617-47312019000200274
work_keys_str_mv AT revillajohannaleiva analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT masidecarolina analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT vieiraluis analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT cadenasjesus analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT aciolyanaclaraferreira analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT paesvictormacedo analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT agiarfranciscoleo analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT celestinojulianajalesdehollanda analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT alvesbennergeraldo analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT pessoaotiliadeusdenialoiola analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT toniolliricardo analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT rodriguesanapaula analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
AT figueiredojosericardode analysisoftheactivityofoncocalyxoneaauxemmaoncocalyxanddoxorubicinontheinvitrodevelopmentofporcineoocytes
_version_ 1756000827884961792